DGI:Endokarditis/Quellen: Difference between revisions
imported>Bestem No edit summary |
imported>Brinkery No edit summary |
||
| Line 1: | Line 1: | ||
==Quellen== | ==Quellen== | ||
Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications: a scientific statement for healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435 | <span style="mso-list:Ignore">1. <span style="font:7.0pt "Times New Roman""> </span></span>Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications: a scientific statement for healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435 | ||
2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128 | <span style="mso-list:Ignore">2. <span style="font:7.0pt "Times New Roman""> </span></span>2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128 | ||
The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241 | <span style="mso-list:Ignore">3. <span style="font:7.0pt "Times New Roman""> </span></span>The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241 | ||
2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551 | <span style="mso-list:Ignore">4. <span style="font:7.0pt "Times New Roman""> </span></span>2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551 | ||
Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6. | <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif; | ||
mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">5. <span style="font:7.0pt "Times New Roman""> </span></span></span>Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6. | |||
POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. N Engl J Med. 28. August 2018. < | <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif; | ||
mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">6. <span style="font:7.0pt "Times New Roman""> </span></span></span>POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. <span style="color: #222222">N Engl J Med. 28. August 2018. </span>[https://doi.org/10.1056/NEJMoa1808312 <span style="font-size:8.0pt;mso-bidi-font-size:10.0pt;font-family:"Calibri",sans-serif; | |||
mso-fareast-font-family:Calibri;letter-spacing:.4pt;background:white; | |||
mso-highlight:white">https://doi.org/10.1056/NEJMoa1808312</span>] | |||
Cahill TJ, Prendergast BD: Infective Endocarditis. Lancet 2016; 387:882-93. | <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif; | ||
mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">7. <span style="font:7.0pt "Times New Roman""> </span></span></span>Cahill TJ, Prendergast BD: Infective Endocarditis. <span style="color: #222222">Lancet 2016; 387:882-93.</span> | |||
< | <span style="font-size:8.0pt;mso-bidi-font-size:11.0pt;font-family:"Calibri",sans-serif; | ||
mso-fareast-font-family:Calibri"><span style="mso-list:Ignore">8. <span style="font:7.0pt "Times New Roman""> </span></span></span>Duval et al.: <span style="mso-font-kerning:18.0pt;mso-bidi-font-weight:bold">Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospec''tive Multicenter TEPvENDO Study. ''</span><span style="font-size:8.0pt;font-family:"Calibri",sans-serif;mso-ascii-theme-font: | |||
minor-latin;mso-hansi-theme-font:minor-latin;mso-bidi-font-family:"Times New Roman"">Clin Infect Dis 2021 Aug 2;73(3):393-403.</span> | |||
<span style="mso-list:Ignore">9. <span style="font:7.0pt "Times New Roman""> </span></span><span style="color: #333333">Fusco, F.M., Pisapia, R., Nardiello, S. ''et al.'' Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. ''BMC Infect Dis'' '''19,''' 653 (2019). </span>[https://doi.org/10.1186/s12879-019-4285-8 <span style="font-size:8.0pt; | |||
font-family:"Calibri",sans-serif;mso-ascii-theme-font:minor-latin;mso-hansi-theme-font: | |||
minor-latin;mso-bidi-font-family:"Segoe UI";background:white">https://doi.org/10.1186/s12879-019-4285-8</span>] | |||
<span style="mso-list:Ignore">10. <span style="font:7.0pt "Times New Roman""> </span></span><span style="color: #212121">Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012 May;54(9):1230-9. doi: 10.1093/cid/cis199. PMID: 22492317.</span> | |||
<span style="color: #212121"><span style="mso-list:Ignore">11. <span style="font:7.0pt "Times New Roman""> </span></span></span><span style="color: #212121">Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012 May 29;59(22):1968-76. doi: 10.1016/j.jacc.2012.02.029. PMID: 22624837.</span> | |||
Revision as of 01:16, 9 March 2022
Quellen
1. Infective endocarditis in adults: diagnosis, antimicrobial therapy and management of complications: a scientific statement for healthcare professionals from the American Heart Association; Circulation (2015); 132(15):1435
2. 2015 ESC Guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European society of cardiology (ESC); European Heart Journal (2015); 36(44):3075-3128
3. The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive Summary; The Journal of Thoracic and Cardiovascular Surgery (2017); 153(6):1241
4. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction.Heart Rhythm. 2017 Dec;14(12):e503-e551
5. Focaccia Siciliano R, Azevedo Randi B, Menosi Gualandro D et al: Early-onset prosthetic valve endocarditis definition revisited: Prospective study and literature review. Int J Inf Dis 2018, 67: 3-6.
6. POET - partial oral treatment of left-sided infectious endocarditis; Ivesen K et al. N Engl J Med. 28. August 2018. https://doi.org/10.1056/NEJMoa1808312
7. Cahill TJ, Prendergast BD: Infective Endocarditis. Lancet 2016; 387:882-93.
8. Duval et al.: Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study. Clin Infect Dis 2021 Aug 2;73(3):393-403.
9. Fusco, F.M., Pisapia, R., Nardiello, S. et al. Fever of unknown origin (FUO): which are the factors influencing the final diagnosis? A 2005–2015 systematic review. BMC Infect Dis 19, 653 (2019). https://doi.org/10.1186/s12879-019-4285-8
10. Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B; AEPEI Study Group. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012 May;54(9):1230-9. doi: 10.1093/cid/cis199. PMID: 22492317.
11. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B; AEPEI Study Group. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012 May 29;59(22):1968-76. doi: 10.1016/j.jacc.2012.02.029. PMID: 22624837.